DEXAMETHASONE
Primary Systemic Amyloidosis
Margarida Magalhaes-SilvermanSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
10 Active assets in the Primary Systemic Amyloidosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CIS-DIAMMINEDICHLOROPLATINUM II Margarida Magalhaes-Silverman | Phase 2 | B |
ETOPOSIDE Margarida Magalhaes-Silverman | Phase 2 | B |
Inno-206 Margarida Magalhaes-Silverman | Phase 2 | B |
Thalidomide Margarida Magalhaes-Silverman | Phase 2 | B |
Bortezomib Margarida Magalhaes-Silverman | Phase 2 | B |
View all 24 →
Same molecule, other indications
DEXAMETHASONE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →